Professor Cyrus Cooper awarded the Heberden Medal of the British Society for Rheumatology

May 12, 2011

Professor Cyrus Cooper, Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit, University of Southampton, has been awarded the Heberden Medal of the British Society for Rheumatology. Professor Cooper has led the Musculoskeletal Research Programme at the University of Southampton for 19 years, and has directed the MRC Unit since 2003.

His research programme has focused on the epidemiology, pathophysiology and prevention of osteoporosis. Discoveries include: (a) documentation of the developmental influences which contribute to the risk of osteoporosis and hip fracture in late adulthood; (b) demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone mineral accrual in childhood; (c) characterisation of the definition and incidence rates of hip, spine and distal forearm fractures; and (d) leadership of large pragmatic randomised controlled trials of calcium and vitamin D supplementation in the elderly, to evaluate these as immediate preventive strategies against hip fracture. Professor Cooper summarised these discoveries in his oration to the British Society for Rheumatology entitled: 'Prevention of osteoporotic fracture: before the cradle and beyond the grave'.

Cyrus Cooper is Chair of the Committee of Scientific Advisors, International Osteoporosis Foundation; Chair of the MRC Population Health Sciences Research Network; Associate Director of Clinical Research at the University of Southampton Medical School; and Associate Editor of the journal 'Osteoporosis International'. He has published extensively (over 450 research papers) on osteoporosis and rheumatic disorders, as well as pioneering clinical studies on the developmental origins of peak bone mass.
-end-
About IOF

The International Osteoporosis Foundation (IOF) is a non-profit, nongovernmental umbrella organization dedicated to the worldwide fight against osteoporosis, the disease known as "the silent epidemic". IOF's members - committees of scientific researchers, patient, medical and research societies and industry representatives from around the world - share a common vision of a world without osteoporotic fractures. IOF now represents 196 societies in 93 locations. http://www.iofbonehealth.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.